Works by Ryang, Soree


Results: 7
    1
    2

    A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1800, doi. 10.1111/dom.14766
    By:
    • Ryang, Soree;
    • Kim, Sang Soo;
    • Bae, Ji Cheol;
    • Han, Ji Min;
    • Kwon, Su Kyoung;
    • Kim, Young Il;
    • Nam‐Goong, Il Seong;
    • Kim, Eun Sook;
    • Kim, Mi‐kyung;
    • Lee, Chang Won;
    • Yoo, Soyeon;
    • Koh, Gwanpyo;
    • Kwon, Min Jeong;
    • Park, Jeong Hyun;
    • Kim, In Joo
    Publication type:
    Article
    3
    4
    5
    6
    7